By Reuters
NYT Business Day
Drugmakers including Roche and Novartis' have agreed to cut the prices of some of their newest drugs by an average of 61% in China in order to get on a national reimbursement scheme list, regulators said.
Published date: November 28, 2019 at 09:04AM
Reuters
New York Times article
No comments:
Post a Comment